Equity Capital Markets

Company · CIK 1651431

Checkmate Pharmaceuticals, Inc.

CIK1651431 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
Listedno ticker on SEC record today
First annual or quarterly report2020-09-18

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-259353
ShelfEffective
 2021-09-072022-06-013
333-239932
IPOFinal prospectus
 2020-07-172020-08-074

Filings

8
FiledFilingRegistrationAccession
2022-06-01EFFECTDeclared effective 333-2593539999999995-22-001653
2021-09-15EFFECTDeclared effective 333-2593539999999995-21-003553
2021-09-07S-3Shelf registered 333-2593530001193125-21-266134
2020-08-07424B4Final prospectus 333-2399320001193125-20-213729
2020-08-06EFFECTDeclared effective 333-2399329999999995-20-002055
2020-08-03S-1/AAmendment 333-2399320001193125-20-207212
2020-07-17S-1Registration filed 333-2399320001193125-20-194796
2020-05-13DRSDraft made public 377-031690000950123-20-004681

All filings of this company · CSV